Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis

Odd Helge Gilja, Alfred Halstensen, A Digranes, Haima Mylvaganam, A. Aksnes, E. Arne Høiby

Antimicrobial Agents and Chemotherapy · 1993 · 44 citations · 12 references

Concepts

Abstract

After an outbreak of three cases of serogroup B meningococcal disease at a Norwegian college, 84 of 392 (21%) subjects were tonsillopharyngeal carriers of Neisseria meningitidis. To eradicate meningococcal carriage, 80 volunteers received a single dose of 400 mg of ofloxacin. Three days after treatment, all 75 evaluable volunteers were culture negative for N. meningitidis, and after 7 days none carried the strain that they carried initially, as judged by DNA fingerprinting. A single dose of ofloxacin was found to be 97.2% effective in eradicating carriage of N. meningitidis for a period of 33 days. The carriage acquisition rate among treated students was four times higher than that among nontreated noncarriers (P = 0.02). After ofloxacin treatment, no case of meningococcal disease occurred for 6 months. Ofloxacin may thus prevent the outbreak and spread of meningococcal disease.

References

12